Application 215113
- Type
- ANDA
- Sponsor
- MSN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 10MG BASE | No | No |
| 002 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 25MG BASE | No | No |
| 003 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 50MG BASE | No | No |
| 004 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 75MG BASE | No | No |
| 005 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 100MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 72205-088 | Doxepin Hydrochloride | Doxepin Hydrochloride | Novadoz Pharmaceuticals LLC | ANDA | Current |
| 72205-089 | Doxepin Hydrochloride | Doxepin Hydrochloride | Novadoz Pharmaceuticals LLC | ANDA | Current |
| 72205-090 | Doxepin Hydrochloride | Doxepin Hydrochloride | Novadoz Pharmaceuticals LLC | ANDA | Current |
| 72205-091 | Doxepin Hydrochloride | Doxepin Hydrochloride | Novadoz Pharmaceuticals LLC | ANDA | Current |
| 72205-092 | Doxepin Hydrochloride | Doxepin Hydrochloride | Novadoz Pharmaceuticals LLC | ANDA | Current |